Volume 30, Number 1—January 2024
Research
Costs of Digital Adherence Technologies for Tuberculosis Treatment Support, 2018–2021
Table 2
Costs of digital adherence technologies for tuberculosis treatment support determined in study of costs of digital adherence technologies for tuberculosis treatment support*
Adherence technology | Variable costs, US$ |
Fixed costs, US$ |
Total costs, US$ |
|||||
---|---|---|---|---|---|---|---|---|
Variable overall | Variable per patient | Fixed overall | Fixed per patient | Total overall | Total per patient | |||
Observed project costs |
||||||||
99DOTS† |
||||||||
Bangladesh, n = 71 |
55,985 |
78 |
14,772 |
21 |
70,756 |
98 |
||
The Philippines, n = 396 |
33,173 |
84 |
13,901 |
35 |
47,074 |
119 |
||
Tanzania, n = 976 |
159,028 |
163 |
10,509 |
11 |
169,536 |
174 |
||
VOT |
||||||||
Haiti, n = 87 |
69,287 |
796 |
31,149 |
358 |
100,436 |
1,154 |
||
Moldova, DS-TB, n = 173 |
34,248 |
198 |
18,429 |
107 |
52,677 |
304 |
||
Moldova DR-TB, n = 135 |
40,088 |
293 |
21,571 |
160 |
61,659 |
452 |
||
Moldova all TB, n = 308 |
74,336 |
242 |
40,000 |
130 |
114,336 |
372 |
||
The Philippines, n = 110 |
45,330 |
412 |
27,327 |
248 |
72,656 |
661 |
||
Project costs annuitized over the 5-y life span of servers and phones |
||||||||
99DOTS |
||||||||
Bangladesh, n = 719 |
60 |
21 |
81 |
|||||
The Philippines, n = 396 |
83 |
8.84 |
92 |
|||||
Tanzania, n = 976 |
160 |
3.61 |
163 |
|||||
VOT |
||||||||
Haiti, n = 87 |
702 |
358 |
1,060 |
|||||
Moldova DS-TB, n = 173 |
151 |
21 |
172 |
|||||
Moldova DR-TB, n = 135 |
222 |
32 |
254 |
|||||
Moldova All TB, n = 308 |
185 |
26 |
211 |
|||||
The Philippines, n = 110 | 247 | 248 | 495 |
*DR-TB, drug-resistant TB; DS-TB, drug-susceptible TB; TB, tuberculosis; VOT, video-observed treatment. †https://www.99dots.org.
Page created: October 31, 2023
Page updated: December 20, 2023
Page reviewed: December 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.